After Death Of Cipla Former Joint Managing Director Amar Lulla, Will Vision Of Veteran Continue?
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - After jointly serving at the helm of Cipla for more than three decades, Joint Managing Director Amar Lulla died April 22 after a prolonged and debilitating battle with cancer. To the world, Cipla Chairman Yusuf Hamied was the face of the company - fighting global pharmaceutical companies to bring down prices of anti-HIV and anti-cancer medications - but to those within the organization, Lulla remained the single driving force, handling the complexities of the generic drugs market in India and working steadily to keep Cipla competitive